What is Imaging Endpoints?
Imaging Endpoints is a science-driven clinical trial imaging company with a specialized focus on oncology-focused imaging services. The firm offers customized and optimized imaging solutions designed to enhance the efficiency and compliance of clinical trials. By leveraging advanced imaging technologies and a team of expert professionals, Imaging Endpoints supports regulatory submissions and plays a crucial role in demonstrating the efficacy of novel treatments in complex clinical trials. Their contributions are vital to global oncology research, aiding in the development of life-changing therapies.
How much funding has Imaging Endpoints raised?
Imaging Endpoints has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Imaging Endpoints
PPP
Public-Private Partnership
What's next for Imaging Endpoints?
The recent major strategic investment signals a new phase of expansion and innovation for Imaging Endpoints. This capital infusion is expected to fuel further development of their advanced imaging technologies and broaden their service offerings to support an increasing number of global oncology trials. The company is well-positioned to capitalize on the growing demand for specialized imaging expertise in drug development, aiming to solidify its leadership in the clinical trial imaging market and accelerate the path to new cancer treatments.
See full Imaging Endpoints company page
